A 65-year-old female is diagnosed with metastatic breast cancer. Which of the following cells would be produced in large quantities to eliminate the tumor cells?

A. "The antibiotic I have been taking doesn't work as well as it used to."
This statement shows awareness of decreased effectiveness, which can occur due to drug resistance. Bacteria can become resistant to antibiotics, leading to reduced efficacy of the medication over time.

B. "The bacteria in my body have become resilient."
This statement correctly attributes resistance to the bacteria. Resilience in this context means that bacteria have developed mechanisms to survive the effects of antibiotics, making the treatment less effective.

C. "Over time, an organism that had once been highly sensitive to an antibiotic may become less susceptible, or it may lose drug sensitivity entirely."
This statement accurately describes the concept of drug resistance. Bacteria can lose sensitivity to antibiotics, rendering the drugs ineffective against them.

D. "My body has become resistant to the antibiotic."
This statement is incorrect. It's the bacteria that develop resistance, not the patient's body. Patients don't become resistant to antibiotics; instead, bacteria evolve and adapt, making the drugs less effective against them.

A. Ototoxicity and Nephrotoxicity:
Ototoxicity: Aminoglycosides can damage the inner ear structures, leading to hearing loss and balance issues.
Nephrotoxicity: These drugs can harm the kidneys, potentially causing acute kidney injury or chronic kidney disease. Monitoring kidney function is crucial to prevent renal damage.

B. Ototoxicity and Cardiotoxicity:
Ototoxicity: As mentioned above, aminoglycosides can damage the inner ear, affecting hearing and balance.
Cardiotoxicity: Aminoglycosides primarily affect the ears and kidneys; they do not directly target the heart. Cardiotoxicity is not a common side effect associated with aminoglycosides.

C. Hepatotoxicity and Nephrotoxicity:
Hepatotoxicity: This term refers to liver damage caused by drugs or toxins. Aminoglycosides are not known to cause liver problems; their primary concern is kidney damage.
Nephrotoxicity: As mentioned earlier, aminoglycosides can harm the kidneys, which is a well-known side effect.

D. Cardiotoxicity and Hepatotoxicity:
Cardiotoxicity: This term refers to the toxic effects on the heart, leading to various heart-related issues. Aminoglycosides do not primarily affect the heart; their main concerns are the ears (ototoxicity) and kidneys (nephrotoxicity).
Hepatotoxicity: Aminoglycosides are not typically associated with liver damage. They are primarily metabolized and excreted by the kidneys, which is why kidney monitoring is crucial during their use.